Soligenix, Inc. Alternatives & Competitors
12 companies similar to Soligenix, Inc. — We are a late-stage biopharmaceutical company focused on developing & commercial...
Companies similar to Soligenix, Inc.
Eloxx Pharmaceuticals
Clinical-stage biopharma company developing novel RNA-modulating drug candidates to treat...
SELLAS Life Sciences Group, Inc.
A late-stage clinical biopharmaceutical company focused on developing novel therapies for...
Eiger BioPharmaceuticals
Developing innovative therapies to treat and cure rare metabolic diseases
Antios Therapeutics
Antios Therapeutics is a clinical-stage biopharmaceutical company devoted to developing th...
Rival Readout
Competing with Soligenix, Inc.? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
X4 Pharmaceuticals
Enabling a better future for people with rare immune disorders
Forma Therapeutics
Dedicated to transforming the lives of patients with rare hematologic diseases and cancers...
Eikon Therapeutics
Eikon is a late-stage clinical biopharmaceutical company dedicated to inventing and develo...
Cytovant Sciences Co., Ltd.
Cytovant is a biopharmaceutical company dedicated to developing novel and innovative cellu...
Rezolute, Inc.
Rezolute is developing transformative therapeutics for rare and metabolic diseases.
AVEO Oncology
Committed to delivering medicines that provide a better life for patients with cancer.
Dynacure
Dynacure develops new treatments for orphan disorders, focusing on CNM through Dyn101 prog...
About Soligenix, Inc.
Soligenix: A late-stage biopharmaceutical company, was founded in 1987. The company's slogan emphasizes its focus on developing and commercializing products to treat rare diseases. Soligenix's Specialized BioTherapeutics business segment is currently working on HyBryte™ (SGX301) for the treatment of cutaneous T-cell ly...
Biopharmaceutical Company, Rare Diseases, Photodynamic Therapy, Vaccine Development, Oncology, Gastrointestinal Disorders, Innovative Therapies, Biodefense, Infectious Diseases, Drug Development, Clinical Research, Regulatory Approval, Government Funding, Late-stage Development
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Soligenix, Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Soligenix, Inc. on 9 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.